Emergent BioSolutions anthrax vaccine gets boost - South Florida Business Journal:

http://www.tradeleadscenter.com/buy/Automobile__automobile
The Rockville-based company’s BioThrax has been granted a shelf life extensiobn from the from its current threwe yearsto four. Under its contract with the Departmenft of Health andHuman Services, the extensioj triggers a milestone payment of $30 million for doses of the vaccine already delivered to the Strategic Nationall Stockpile. Emergent expects to record that payment as revenue this The shelf life extension also allows Emergenft to charge more for future doses of the vacciner delivered tothe government’s That could raise the value of the contractt to as much as $405 million over the next severapl years.
Last year, the FDA approved a reduced vaccination scheduled tofive doses. Emergent continues research that could lead to a furthee reduction in the number ofdoses required, as well as the vaccine’zs use to treat patients after beingh exposed to Anthrax, not just as a pre-exposuree vaccine. Emergent has supplied the government’ss stockpile with 33 million doses of BioThraxso far. It is contracted to continur adding to stockpiles throughlate 2011. BioThrax has been used to vaccinat e more than 2 million military personnel sincse the government first started buying the vaccinein 1998. Emergent stocjk (NYSE: EBS) was up 90 centws to $14.63 per share in afternoon trading.